Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. SFA_09062023_Phramalogistica_114_espi.pdf A transaction concluded by the subsidiary "Pharmalogistika" AD under Art. 114, para. 3 of the Law on Public Offering of Securities requiring prior approval of the public company

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 44 / 2023
Date of issue: 2023-06-09
Short name of the issuer
SOPHARMA AD
Subject
A transaction concluded by the subsidiary "Pharmalogistika" AD under Art. 114, para. 3 of the Law on Public Offering of Securities requiring prior approval of the public company
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
“Sopharma” AD (the Company) hereby informs that following a request made to the parent company "Sopharma" AD by the subsidiary "Pharmalogistika" AD and the consent given by the Board of Directors on 06.06.2023, today the subsidiary concluded the following transaction falling within the scope of Art. 114 para. 3 of the Securities Act:
Annexes
File Description
SFA_09062023_Phramalogistica_114_espi.pdf
SFA_09062023_Phramalogistica_114_espi.pdf		 A transaction concluded by the subsidiary "Pharmalogistika" AD under Art. 114, para. 3 of the Law on Public Offering of Securities requiring prior approval of the public company

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2023-06-09 Ognian Donev Executive Director
20230609_122436_1497619859_SFA_09062023_Phramalogistica_114_espi.pdf

Pobierz